A Polymerase Chain Reaction (PCR) Market Forecasts to 2030 – Global Analysis By Product (Instruments, Reagents, Consumables and Other Products)

Polymerase Chain Reaction (PCR) Market Forecasts to 2030 – Global Analysis By Product (Instruments, Reagents, Consumables and Other Products), Application (Oncology, Blood Testing, Pathogen Detection, Research, Forensic and Other Applications), End User and By Geography

According to Stratistics MRC, the Global Polymerase Chain Reaction (PCR) Market is accounted for $8.9 billion in 2023 and is expected to reach $19.1 billion by 2030 growing at a CAGR of 11.5% during the forecast period. Polymerase Chain Reaction (PCR) is a molecular method for producing millions of copies of a particular DNA strand through in-vitro amplification. PCR is highly sensitive and can detect minute quantities of DNA. This is particularly advantageous in applications where the target DNA is present in low concentrations, such as in the early stages of certain diseases or when analyzing trace amounts of DNA in forensic samples.

According to Indian Council of Medical Research (ICMR), there will be a 12 percent rise in cancer cases in India by the 2027.

Market Dynamics:

Driver:

Rising demand for genetic testing

The rising demand for genetic testing has been a significant driver in the polymerase chain reaction (PCR) market. Genetic testing involves the analysis of an individual's DNA to identify genetic variations, mutations, and gene expression patterns. PCR plays a crucial role in this process by amplifying specific DNA sequences for further analysis. Additionally, genetic testing has gained popularity among individuals who are curious about their ancestry and want to explore their genetic heritage. Therefore, these advancements have expanded the applications of PCR in genetic testing, contributing to the growth of the PCR market.

Restraint:

High cost

The initial investment in PCR instruments, reagents, and consumables, coupled with the need for skilled personnel, contributes to the overall expense, especially for smaller diagnostic facilities and laboratories. The sophisticated nature of PCR equipment and the continuous requirement for quality control further add to the operational costs. Additionally, the expense of PCR tests may burden patients and healthcare systems, impacting the affordability and equitable distribution of cutting-edge diagnostic services. Therefore, high costs are a significant barrier to market expansion.

Opportunity:

Technological advancements

Real-time PCR allows for the detection and quantification of PCR amplification in real-time, providing immediate results during the amplification process. This real-time monitoring enables faster and more precise analysis, making it valuable in fields such as clinical diagnostics, genetic testing, and research. Furthermore, advancements in PCR instrument technology have resulted in more user-friendly and automated systems. Integrated thermal cyclers with advanced temperature control algorithms and intuitive software interfaces have made PCR more accessible to a broader range of users, including researchers, clinicians, and technicians. These advancements in technology are a significant factor in accelerating market demand.

Threat:

Complexity and technical expertise

A certain level of technical knowledge and training is required for the various steps involved in PCR techniques, which include primer design, reaction condition optimization, and data analysis. PCR protocols require careful design and selection of primers that specifically target the desired DNA regions. Designing primers with appropriate melting temperatures, avoiding secondary structures, and minimizing primer-dimer interactions can be challenging. The complexity and technical expertise required to perform polymerase chain reaction (PCR) act as restraints in the polymerase chain reaction (PCR) market.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the polymerase chain reaction market growth. The growing demand in the clinical diagnostic market segment had a favourable effect on the PCR market. Healthcare professionals advised the population exhibiting COVID-19 symptoms to have a diagnostic test performed, and nearly all of these tests use RT-PCR since viral culture tests have not been recommended by the authorities. Most pharmaceutical and biotechnological companies were focusing on the research and development departments to identify new molecules or leads for the treatment of COVID-19.

The reagents segment is expected to be the largest during the forecast period

The reagents segment is estimated to hold the largest share. PCR reagents encompass a range of chemicals, including DNA polymerases, primers, nucleotides, and buffers, each playing a specific role in the reaction. DNA polymerases, such as Taq polymerase, catalyze the synthesis of complementary DNA strands, while primers provide the starting points for DNA amplification. Nucleotides serve as building blocks for the newly synthesized DNA strands, and buffers maintain the optimal pH conditions for enzymatic activity. The demand for high-quality and reliable reagents is paramount for the accuracy and efficiency of PCR reactions.

The diagnostic center segment is expected to have the highest CAGR during the forecast period

The diagnostic center segment is anticipated to have lucrative growth during the forecast period. PCR technology is extensively utilized in diagnostic centers for the detection of various diseases, including infectious agents, genetic disorders, and cancer. Diagnostic centers leverage PCR's high sensitivity and specificity to identify and quantify specific DNA or RNA sequences, aiding in the early and precise diagnosis of diseases. The versatility of PCR enables diagnostic centers to offer a wide range of tests, contributing to comprehensive patient care.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The high frequency of diseases, the presence of important players in the region, the existence of favourable regulations, and a number of government initiatives pertaining to advancements in healthcare infrastructure all contribute to the growth of the regional market. An additional factor fueling the growth is growing patient awareness of the availability of contemporary products for successful diagnosis.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, owing to the rising incidence of infectious diseases, the growing recognition of personalized medicine, and the improvements made to the healthcare system. Asian countries are seeing an increase in research endeavours, specifically in the fields of genomics, oncology, and infectious disease investigations. This has led to the widespread use of PCR as a precise and efficient method of amplifying DNA. Moreover, the region's diverse population and genetic variations necessitate robust molecular diagnostics for personalized treatment strategies, further fueling the PCR market.

Key players in the market

Some of the key players in the Polymerase Chain Reaction (PCR) Market include Danaher Corporation, Fluidigm Corporation, Agilent Technologies, Inc., Stilla Technologies, Abbott, Cytiva, Microsynth AG, Qiagen, JN Medsys, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Siemens, Johnson & Johnson Private Limited and Bruker.

Key Developments:

In August 2022, Abbott and weightwatchers partner to support people living with diabetes in attaining their health goals. Two industry leaders join forces to empower people living with diabetes by providing information and insights to improve weight loss, glucose control and overall health.

In June 2021, Bio-Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, announced a partnership with Seegene, Inc., a global leader in multiplex molecular diagnostics, for the clinical development and commercialization of infectious disease molecular diagnostic products.

Products Covered:
• Instruments
• Reagents
• Consumables
• Other Products

Applications Covered:
• Oncology
• Blood Testing
• Pathogen Detection
• Research
• Forensic
• Other Applications

End Users Covered:
• Pharmaceutical
• Hospital
• Clinical Research Organizations
• Diagnostic Center
• Academia
• Laboratories
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements